Issue 9, 2017

Polyhydroxyalkanoates as biomaterials

Abstract

Polyhydroxyalkanoates (PHAs) are biopolymers synthesized by bacteria under unbalanced growth conditions. These biopolymers are considered as potential biomaterials for future applications because they are biocompatible, biodegradable, and easy to produce and functionalize with strong mechanical strength. Currently, PHAs are being extensively innovated for biomedical applications due to their prerequisite properties. The wide range of biomedical applications includes drug delivery systems, implants, tissue engineering, scaffolds, artificial organ constructs, etc. In this article we review the utility of PHAs in various forms (bulk/nano) for biomedical applications so as to bring about the future vision for PHAs as biomaterials for the advancement of research and technology.

Graphical abstract: Polyhydroxyalkanoates as biomaterials

Associated articles

Article information

Article type
Review Article
Submitted
21 May 2017
Accepted
23 Jun 2017
First published
27 Jun 2017

Med. Chem. Commun., 2017,8, 1774-1787

Polyhydroxyalkanoates as biomaterials

B. S. Thorat Gadgil, N. Killi and G. V. N. Rathna, Med. Chem. Commun., 2017, 8, 1774 DOI: 10.1039/C7MD00252A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements